- COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
Sujie Gu et al, 2021, Frontiers in Oncology CrossRef - The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi et al, 2020, Frontiers in Immunology CrossRef - Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
Yuxiang Fan et al, 2021, Frontiers in Immunology CrossRef - Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia
Shih-Chung Yen et al, 2021, Journal of Natural Products CrossRef - Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis
Fang Cao et al, 2021, Cancer Management and Research CrossRef - RID: Evaluation of the Possible Inhibiting Effect of the Proinflammatory Signaling Induced by TNF-α through NF-κβ and AP-1 in Two Cell Lines of Breast Cancer
F. A. Monsalve et al, 2020, Mediators of Inflammation CrossRef - Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment
Elena Codrici et al, 2022, International Journal of Molecular Sciences CrossRef